Open access · CC-BY
via OpenAlex
Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts
Nutrients · 2022 · ▲ 62 citations
Abstract
The preservation of cognitive ability by increasing nicotinamide adenine dinucleotide (NAD+) levels through supplementation with NAD+ precursors has been identified as a promising treatment strategy for a number of conditions; principally, age-related cognitive decline (including Alzheimer’s disease and vascular dementia), but also diabetes, stroke, and traumatic brain injury. Candidate factors have included NAD+ itself, its reduced form NADH, nicotinamide (NAM), nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), and niacin (or nicotinic acid). This review summarises the research findings for each source of cognitive impairment for which NAD+ precursor supplementation has been investigated as a therapy. The findings are mostly positive but have been made primarily in animal models, with some reports of null or adverse effects. Given the increasing popularity and availability of these factors as nutritional supplements, further properly controlled clinical research is needed to provide definitive answers regarding this strategy’s likely impact on human cognitive health when used to address different sources of impairment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/nu14153231
- Canonical
- link ↗
- Fetched
- 2026-08-25 MST
Cite this
APA
Campbell, J.M. (2022). Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts. <em>Nutrients</em>. https://doi.org/10.3390/nu14153231
Vancouver
Campbell JM. Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts. Nutrients. 2022. doi:10.3390/nu14153231.
BibTeX
@article{jared2022Supple,
title = {Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts},
author = {Jared M. Campbell},
journal = {Nutrients},
year = {2022},
doi = {10.3390/nu14153231},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The FASEB Journal 2024
Open access · OA
Exploring nicotinamide adenine dinucleotide precursors across biosynthesis pathways: Unraveling their role in the ovary
Nutrients 2023
Open access · CC-BY
Defining NAD(P)(H) Catabolism
2016
Preprint · OA
Novel NAD+ metabolomic technologies and their applications to Nicotinamide Riboside interventions
Cells 2026
Open access · CC-BY
Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling
Antioxidants 2024
Open access · CC-BY
The Role of Nicotinamide Mononucleotide Supplementation in Psoriasis Treatment
Molecular Metabolism 2019
Open access · CC-BY